IP Library › Granted Patent US 11,007,199
Granted Patent B2
US 11,007,199 · App. 16/738,439 · Granted May 18, 2021

Compositions and methods for ameliorating pain and reducing fever

Inventors: Nicolas Bazan (New Orleans, LA); Hernan Bazan (New Orleans, LA); Julio Alvarez-Builla Gomez (Madrid, ES); Dennis Paul (New Orleans, LA); Carolina Burgos Garcia (Madrid, ES)
Assignees: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College; University of Alcala De Hernares; South Rampart Pharma, LLC
A61K31/5375A61K31/18A61K31/40A61K31/4402A61K31/495A61K45/06A61P23/00A61P29/00C07C311/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,199
App. No.
16/738,439
Granted
May 18, 2021
Kind
B2
Abstract

This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.

Claims (7)

1. An analgesic compound having the following chemical structure:

2. The analgesic compound of claim 1 , wherein said compound exhibits analgesic effects comparable to acetaminophen when administered in vivo in the same amount.

3. The analgesic compound of claim 1 , wherein said compound has a exhibits reduced risk of hepatotoxicity comparable to acetaminophen when administered in vivo in the same amount.

4. An antipyretic compound having the following chemical structure:

5. The antipyretic compound of claim 4 , wherein said compound exhibits reduced risk of hepatotoxicity comparable to acetaminophen when administered in vivo in the same amount.

6. A method of treating pain in a patient, the method comprising administering to said patient a therapeutically effective amount of a compound having the following chemical structure:

7. A method of treating fever in a patient, the method comprising administering to said patient a therapeutically effective amount of a compound having the following chemical structure:

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 12, 2022
From: LSU HEALTH SCIENCES CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061656/0087 →
Continuity (3)
Continuation In Part PCTUS2018022029 · Mar 12, 2018
Provisional Application 62550137 · Aug 25, 2017
Related Publication 20200230087A1 · Jul 23, 2020